Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      Subscribe Login/Register
      S&P 500
      4,288.05
      (
      -0.27%
      )
      US Tech 100
      14,346.00
      (
      0.18%
      )
      Dow Jones
      33,507.50
      (
      -0.47%
      )
      Brent Oil
      92.015
      (
      0.0%
      )
      Bitcoin
      26,920.81
      (
      0.04%
      )
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NASDAQ
      6. CytoSorbents Corporation (CTSO)

      7. CytoSorbents Corporation (CTSO) News

      CTSO CytoSorbents Corporation

      1.88
      0.02 (1.08%)
      Sep 29 2023 - Closed
      Delayed by 15 minutes

      Register Free for Streaming Quotes & Tools

      Register for Free to get streaming quotes, interactive charts, trades, portfolio, live options flow and more.

      Register
      Company Name Stock Ticker Symbol Market Type
      CytoSorbents Corporation CTSO NASDAQ Common Stock
        Price Change Change Percent Stock Price Last Traded
      Upgrade Icon
      0.02 1.08% 1.88 18:00:03
      Open Price Low Price High Price Close Price Prev Close
      1.88 1.82 1.99 1.88 1.86
      more quote information »

      Recent News

      Date Time Source Heading
      9/29/202310:16IHNWFeaturedVolcon Announces First Shipment of Newly Updated Grunt EVO Electric Motorcycle Units
      9/27/202308:15EDGAR2Form 8-K - Current report
      9/27/202307:00GLOBECytoSorbents Highlights Upcoming Presentations at EACTS..
      9/21/202309:35GLOBEDawson James Securities Announces October Date for 8th..
      9/20/202316:34EDGAR2Form 4 - Statement of changes in beneficial ownership of..
      9/19/202316:30EDGAR2Form 8-K - Current report
      9/19/202307:00GLOBECytoSorbents Announces Kathleen P. Bloch To Resume as..
      9/12/202316:31EDGAR2Form 8-K - Current report
      9/11/202311:32GLOBECytoSorb with Ex Vivo Organ Perfusion: Transforming the..
      9/01/202316:43GLOBECytoSorbents Announces Resignation of Chief Financial..
      9/01/202316:30EDGAR2Form 8-K - Current report
      8/31/202307:00GLOBECytoSorbents Granted Expanded ANVISA Registration to Treat..
      8/15/202317:57EDGAR2Form 3 - Initial statement of beneficial ownership of..
      8/14/202307:00PRNUSCytoSorbents Completes U.S. and Canadian STAR-T Pivotal..
      8/11/202317:30EDGAR2Form 8-K - Current report
      8/08/202320:01EDGAR2Form 4 - Statement of changes in beneficial ownership of..
      8/01/202316:15GLOBECytoSorbents Reports Second Quarter 2023 Financial and..
      8/01/202316:13EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
      7/26/202307:00GLOBECytoSorbents to Report Second Quarter 2023 Operating and..
      7/19/202317:19EDGAR2Form 8-K - Current report
      7/11/202320:31EDGAR2Form 4 - Statement of changes in beneficial ownership of..
      7/11/202320:31EDGAR2Form 4 - Statement of changes in beneficial ownership of..
      7/11/202320:31EDGAR2Form 4 - Statement of changes in beneficial ownership of..
      7/11/202320:31EDGAR2Form 4 - Statement of changes in beneficial ownership of..
      7/11/202320:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
      7/11/202320:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
      7/11/202320:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
      7/11/202320:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
      7/11/202317:21EDGAR2Form 8-K - Current report
      7/11/202307:00GLOBECytoSorbents And Humedics Announce Theranostic Collaboration..
      7/07/202316:31EDGAR2Form 8-K - Current report
      7/07/202307:07GLOBECytoSorbents Completes Enrollment of the STAR-T Pivotal..
      6/15/202307:00GLOBECytoSorbents Announces Independent Data Safety and..
      6/05/202309:00GLOBECytoSorbents This Week to Host its Virtual Annual..
      5/02/202316:15GLOBECytoSorbents Reports First Quarter 2023 Results
      4/26/202307:00GLOBECytoSorbents to Report First Quarter 2023 Operating and..
      4/20/202307:00GLOBECytoSorbents’ Pivotal STAR-T Trial Reaches Second Key..
      4/19/202307:00GLOBECytoSorbents Announces Board Chairman Al W. Kraus To Retire
      3/29/202308:30GLOBELandmark Publication Underscores Robust Ability of CytoSorb..
      3/22/202308:09GLOBECytoSorbents Highlights New Clinical Data from Current..
      3/14/202307:00GLOBECytoSorbents Comments on Bank Exposure and Diversified Cash..
      3/09/202316:15GLOBECytoSorbents Reports Fourth Quarter and Full Year 2022..
      3/07/202307:00GLOBENew European “Guidelines for the Management of Severe..
      2/27/202307:00PRNUSCytoSorbents to Present at the Cowen 43rd Annual Health Care..
      2/24/202307:00PRNUSCytoSorbents to Report Fiscal 2022 Operating and Financial..
      1/31/202307:15PRNUSCytoSorbents Issues Stockholder Letter and Reports..
      1/23/202307:00PRNUSCytoSorbents Announces Health Canada Regulatory Approval For..
      1/17/202307:00PRNUSCytoSorbents Appoints Irina B. Kulinets, PhD, as Senior Vice..
      12/29/202207:00PRNUSCytoSorbents Receives $5M in Non-Dilutive Debt Financing..
      12/21/202215:40APSHealthcare Microcap Pops On DSMB Recommendation
      12/21/202207:00PRNUSCytoSorbents Receives Recommendation from Independent Data..
      Your Recent History
      NASDAQ
      CTSO
      CytoSorben..
      Register now to watch these stocks streaming on the ADVFN Monitor.

      Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

      Log in to InvestorsHub
      Register Now